Treatment entry among individuals on a waiting list for methadone maintenance

American Journal of Drug and Alcohol Abuse

Volumn 35, Issue 5, 2009, Pages 290-294

  Gryczynski, Jan ^a   Schwartz, Robert ^a   O'Grady, Kevin ^b   Jaffe, Jerome ^a  

^a FRIENDS RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

Author keywords

Methadone; Motivation; Treatment entry; Waiting list

Indexed keywords

COCAINE; DIAMORPHINE; METHADONE;

ADULT; ARTICLE; CLINICAL ASSESSMENT; COCAINE DEPENDENCE; FEMALE; FOLLOW UP; HEALTH PROGRAM; HEROIN DEPENDENCE; HOSPITAL ADMISSION; HUMAN; INTRAVENOUS DRUG ABUSE; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; METHADONE TREATMENT; MOTIVATION; OUTCOME ASSESSMENT; PREDICTION; URINALYSIS;

ADULT; FEMALE; HEROIN DEPENDENCE; HUMANS; MALE; METHADONE; MIDDLE AGED; MOTIVATION; NARCOTIC ANTAGONISTS; PATIENT ADMISSION; QUESTIONNAIRES; REGRESSION ANALYSIS; SOCIAL ENVIRONMENT; SUBSTANCE ABUSE TREATMENT CENTERS; TREATMENT OUTCOME; WAITING LISTS;

EID: 73349139570     PISSN: 00952990     EISSN: 10979891     Source Type: Journal    
DOI: 10.1080/00952990902968577     Document Type: Article

References (25)

1. NIH Consensus Development Panel. Effective medical treatment of opiate addiction. J Am Med Assoc 1988; 280(22):1936-1943.
2. Friedmann PD, Lemon SC, Stein MD, D'Aunno T. Accessibility of addiction treatment: Results from a national survey of outpatient substance abuse treatment organizations. Health Serv Res 2003; 38(3):887-903.
3. Redko C, Rapp RC, Carlson RG. Waiting time as a barrier to treatment entry: Perceptions of substance users. J Drug Issues 2006; 36(4):831-852.
4. Hser YI, Maglione M, Polinsky ML, Anglin MD. Predicting drug treatment entry among treatment-seeking individuals. J Sub Abuse Treat 1998; 15(3):213-220.
5. Corsi KF, Kwiatkowski CF, Booth RE. Treatment entry and predictors among opiate-using injection drug users. Am J Drug Alcohol Abuse 2007; 33(1):121-127.
6. Carr CJ,Xu J, Redko C, Lane DT, Rapp RC, Goris J, Carlson RG. Individual and system influences on waiting time for substance abuse treatment. J Sub Abuse Treat 2008; 34(2):192-201.
7. Neff JA, Zule WA. Predictive validity of a measure of treatment readiness for out-of-treatment drug users: Enhancing prediction beyond demographic and drug history variables.AmJ Drug Alcohol Abuse 2002; 28(1):147-169.
8. Joe GW, Simpson D, Broome KM. Effects of readiness for drug abuse treatment on client retention and assessment of process. Addiction 1998; 93(8):1177-1190.
9. Burke BL, Arkowitz H, Menchola M. The efficacy of motivational interviewing: Ameta-analysis of controlled clinical trials. J ConsultClin Psychol 2003; 71(5):843-861.
10. Donovan DM, Rosengren DB, Downey L, Cox GB, Sloan KL. Attrition prevention with individuals awaiting publicly funded drug treatment. Addiction 2001; 96(8):1149-1160.
11. Booth RE, Kwiatkowski C, Iguchi MY, Pinto F, John D. Facilitating treatment entry among out-of-treatment injection drug users. Public Health Rep 1998; 113(S1):116-128.
12. Booth RE, Corsi KF, Mikulich SK. Improving entry to methadone maintenance among out-of-treatment injection drug users. J Sub Abuse Treat 2003; 24(4):305-311.
13. Kidorf M, Disney E, King V, Kolodner K, Beilenson P, Brooner P. Challenges in motivating treatment enrollment in community syringe exchange programs. J Urban Health 2005; 82(3):456-467.
14. Schwartz RP, Highfield DA, Jaffe JH, Brady JV, Butler CA, Rouse CO, Callaman JM, O'Grady KE, Battjes RJ. A randomized controlled trial of interim methadone maintenance. Arch Gen Psych 2006; 63(1):102-109.
15. McLellan AT, Cacciola JS, Alterman AI, Rikoon SH, Carise D. The Addiction Severity Index at 25: Origins, contributions, and transitions. Am J Addict 2006; 15(2):113-124.
16. Knight K, HolcomM, Simpson DD.TCUpsychosocial functioning andmotivation scales: manual on psychometric properties. Institute of Behavioral Research, Texas Christian University, Ft. Worth, TX, 1994. Available at at: http://www.ibr.tcu.edu/pubs/datacoll/kk6-srf-95.pdf. Last accessed December 11, 2008.
17. Kennedy P. A Guide to Econometrics (5th ed.). Cambridge,MA: MIT Press, 2003.
18. Norton EC, Wang H, Ai C. Computing interaction effects and standard errors in logit and probit models. The Stata Journal 2004; 4(2):154-167.
19. Darke S, Hall W. Heroin overdose: research and evidence-based interventions. J Urban Health 2003; 89(2):189-200.
20. GossopM,Griffiths P, Powis B, Strang J. Severity of heroin dependence and HIV risk. II. Sharing injection equipment. AIDS Care 1993; 5(2):159-168. (Pubitemid 23180928)
21. Nurco D. A long-term program of research on drug use and crime. Subst Use Misuse 1998; 33(9):1817-1837.
22. General Accounting Office. Some Clinics not Meeting Goal of Prompt Treatment for Intravenous Drug Users. (GAO/HRD-90-80BR). Washington, DC: General Accounting Office, 1990.
23. Schwartz RP, Highfield DA, Jaffe JH, Callaman JM, O'Grady KE. A randomized controlled trial of interim methadone maintenance: 10-month follow-up. Drug Alcohol Depend 2007; 86(1):30-36.
24. Center for Substance Abuse Treatment. Assessment and treatment of cocaine-abusing methadone-maintained patients. Treatment Improvement Protocol #10 (TIP10). DHHS Publication No. (SMA) 94-3003. Washington, DC: Substance Abuse and Mental Health Services Administration, Department of Health and Human Services, 1994.
25. Appel PW, Ellison AA, Jansky HK, Oldak R. Barriers to enrollment in drug abuse treatment and suggestions for reducing them: opinions of drug injecting street outreach clients and other system stakeholders. Am J Drug Alcohol Abuse 2004; 30(1):129-153.